Analysts See $-0.03 EPS for Profound Medical Corp. (PRN)

October 13, 2018 - By whatsonthorold

Analysts expect Profound Medical Corp. (TSE:PRN) to report $-0.03 EPS on November, 6.They anticipate $0.06 EPS change or 66.67 % from last quarter’s $-0.09 EPS. After having $-0.05 EPS previously, Profound Medical Corp.’s analysts see -40.00 % EPS growth. It closed at $0.59 lastly. It is down 0.00% since October 14, 2017 and is . It has underperformed by 15.62% the S&P500.

Profound Medical Corp. operates as a medical device firm focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. The company has market cap of $63.75 million. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids, and palliative pain treatment of bone metastases. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>